中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
Viral Diseases
NASH/PBC
Cancer
Exploratory Indications
Products&Pipeline
Pipeline
Products
Clinical Trials
Partnership
Investors
Financials & Filing
Presentation Materials
News
Careers
Investors
Financials & Filing
Presentation Materials
Next Day Disclosure Returns - Share Buyback / Others
2021-12-07
Next Day Disclosure Returns - Share Buyback
2021-12-06
Next Day Disclosure Returns - Share Buyback
2021-12-03
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2021
2021-12-03
Announcement - Inside Information - Inclusion in New Catalogue of China National Reimbursement Drug List (NRDL) of ASCLEVIR®/GANOVO® Regimen, an All-Oral Direct Anti-HCV Therapy and Resumption of Trading
2021-12-03
Trading Halt
2021-12-03
Next Day Disclosure Returns - Share Buyback
2021-12-02
Next Day Disclosure Returns - Share Buyback
2021-12-01
Next Day Disclosure Returns - Share Buyback
2021-11-30
Next Day Disclosure Returns - Share Buyback
2021-11-29
1
2
3
4
»
